Clinical Trial Update: Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis [Phase 1, Phase 2]

View source ↗

Summary

The document describes a Phase 1/2 clinical trial evaluating adoptive cord blood immunotherapy to prevent or treat reactivation/infection with Epstein-Barr viru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Bk Virus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• Adoptive cord blood immunotherapy (Cord blood-derived virus-specific T cells)

Snippet

Sponsor: Catherine Bollard | Conditions: Viral Infection | Phase 1, Phase 2 | Status: RECRUITING